{"id":357421,"date":"2026-08-26T13:05:06","date_gmt":"2026-08-26T13:05:06","guid":{"rendered":"https:\/\/www.europesays.com\/at\/357421\/"},"modified":"2026-08-26T13:05:06","modified_gmt":"2026-08-26T13:05:06","slug":"aus-fuer-insolventen-arzneihersteller-r-pharm-wirtschaft","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/at\/357421\/","title":{"rendered":"Aus f\u00fcr insolventen Arzneihersteller R-Pharm &#8211; Wirtschaft"},"content":{"rendered":"<p>Illertissen \u2013 Die insolvente deutsche Tochter des russischen Medikamentenherstellers R-Pharm wird abgewickelt, die 280 Mitarbeiter verlieren ihre Arbeitspl\u00e4tze. Die monatelange Suche nach einem rettenden Investor f\u00fcr das in Illertissen im Allg\u00e4u beheimatete Unternehmen ist nach Angaben des Insolvenzverwalters Markus Fr\u00f6hlich erfolglos geblieben. Die beiden zum Schluss noch verbliebenen \u00dcbernahmeinteressenten konnten demnach den Nachweis einer gesicherten Finanzierung nicht erbringen.<\/p>\n","protected":false},"excerpt":{"rendered":"Illertissen \u2013 Die insolvente deutsche Tochter des russischen Medikamentenherstellers R-Pharm wird abgewickelt, die 280 Mitarbeiter verlieren ihre Arbeitspl\u00e4tze.&hellip;\n","protected":false},"author":2,"featured_media":357422,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[14],"tags":[46,42,95,90,89,91,94,44,93,92],"class_list":["post-357421","post","type-post","status-publish","format-standard","has-post-thumbnail","category-unternehmen-maerkte","tag-at","tag-austria","tag-business","tag-companies","tag-companies-markets","tag-markets","tag-maerkte","tag-oesterreich","tag-unternehmen","tag-unternehmen-maerkte"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@at\/117161959349149153","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/posts\/357421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/comments?post=357421"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/posts\/357421\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/media\/357422"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/media?parent=357421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/categories?post=357421"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/at\/wp-json\/wp\/v2\/tags?post=357421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}